Strategies for Maintaining Weight Loss After Discontinuing GLP-1 Medications

Research indicates that having a solid plan in place can significantly improve the chances of maintaining weight loss after stopping GLP-1 (glucagon-like peptide-1) medications. A recent study from the Cleveland Clinic, presented at ObesityWeek and published in eClinicalMedicine, suggests that individuals should consider alternatives, such as switching medications or undergoing bariatric surgery, rather than ceasing treatment altogether.

The study analyzed data from over 20,000 adults diagnosed with obesity or type 2 diabetes. It compared five strategies for managing weight after GLP-1 treatments: continuing the same medication, switching between semaglutide (Ozempic) and tirzepatide (Zepbound), changing to different weight-loss medications, undergoing bariatric surgery, and stopping treatment completely. The results revealed that those who underwent bariatric surgery or switched between GLP-1 medications experienced the most significant weight loss.

Participants who opted for bariatric surgery lost an average of 28.2% of their body weight, roughly 31.5 kg (69.4 lbs), over two years. In contrast, those who switched between GLP-1 medications lost about 16% of their body weight, or around 18 kg (39.6 lbs). For those who continued with their original GLP-1 medication, the weight loss was limited to approximately 10.9% (12.3 kg or 27.1 lbs), while those who transitioned to another weight-loss medication saw a loss of about 8.2% (9.2 kg or 20.2 lbs). The least weight loss, only 4% (4.5 kg or 9.9 lbs), was observed in individuals who completely stopped their GLP-1 treatment.

Experts underscore the importance of devising a long-term weight management strategy prior to discontinuing GLP-1 medications. Increased hunger and weight regain are common after stopping treatment, and healthcare professionals can assist in developing a comprehensive plan to address these challenges.

Dr. Mir Ali, a medical director at MemorialCare Surgical Weight Loss Center, emphasizes that medications and surgical options should be viewed as complementary rather than exclusive. For patients with severe obesity, bariatric surgery remains a highly effective method for sustainable weight loss. Additionally, using GLP-1 medications before surgery can reduce risks and improve outcomes.

To further support weight maintenance after discontinuing GLP-1 medications, experts recommend focusing on nutrition and physical activity. Prioritizing protein intake and engaging in resistance training can help preserve muscle mass and boost metabolism. Collaborating with a registered dietitian can also foster healthier eating habits, emphasizing the consumption of fiber-rich foods and balanced meals.

Before making any decisions about stopping GLP-1 medications, individuals are encouraged to consult with healthcare providers. Identifying the reasons behind discontinuation—whether due to side effects, insurance coverage, or other issues—is essential. Adjusting the dosage or switching to another medication can often alleviate side effects.

In conclusion, having a well-defined exit strategy is crucial for anyone considering stopping GLP-1 treatment. With the right support and planning, individuals can maintain the weight loss they have achieved and continue on their path to better health.

Similar Posts